The Management of Acute Onset Complete Heart Block and Atrial Flutter in a Patient with COVID-19

  • Murtaza Hussain Department of Internal Medicine, Michigan State University at Hurley Medical Center, Flint, MI, USA
  • Dominic Awuah Department of Internal Medicine, Michigan State University at Hurley Medical Center, Flint, MI, USA
  • Smit Deliwala Department of Internal Medicine, Michigan State University at Hurley Medical Center, Flint, MI, USA
  • Luay Alkotob Department of Internal Medicine, Division of Cardiology, Michigan State University at Hurley Medical Center, Flint, MI, USA
  • Elfateh Seedahmed Department of Internal Medicine, Division of Pulmonary Critical Care, Michigan State University at Hurley Medical Center, Flint, MI,USA
  • Ghassan Bachuwa Department of Internal Medicine, Michigan State University at Hurley Medical Center, Flint, MI, USA

Keywords

Complete heart block, atrial flutter, COVID-19 infection

Abstract

SARS-CoV-2 has infected millions of people worldwide. Its cardiac presentations include myocarditis, arrhythmias and structural heart changes even in young and healthy individuals. The long-term sequelae of these manifestations are unknown. We describe a unique combination of complete heart block and atrial flutter in the setting of COVID-19. SARS-CoV-2 virulence mechanisms can cause fibrosis in the myocardium resulting in loss of sinus node dominance. The paradoxical finding of atrial flutter and complete heart block is very rare. Prompt cardiac evaluation and electrophysiological testing are important. Cardiac magnetic resonance imaging (cMRI) and endomyocardial biopsies are the gold standard investigations. Anticoagulation should be administered until atrioventricular synchrony is achieved.

VIEW THE ENTIRE ARTICLE

References

  • Bai Y, Yao L, Wei T, Tian F, Jin D-Y, Chen L, et al. Presumed asymptomatic carrier transmission of COVID-19.JAMA 2020;323(14):1406–1407.
  • Mackenzie JS, Smith DW. COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don’t. Microbiol Aust 2020;41(1):45–50.
  • Lakkireddy DR, Chung MK, Gopinathannair R, Patton KK, Gluckman TJ, Turagam M, et al. Guidance for cardiac electrophysiology during the COVID-19 pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association. Circulation 2020;141(21):e823–e831.
  • Kochi AN, Tagliari AP, Forleo GB, Fassini GM, Tondo C. Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovasc Electrophysiol 2020;31(5):1003–1008.
  • Bao C, Liu X, Zhang H, Li Y, Liu J. Coronavirus disease 2019 (COVID-19) CT findings: a systematic review and meta-analysis. J Am Coll Radiol 2020;17(6):701–709.
  • Newcombe CP, De Souza D, Towers JRH. Atrial flutter with complete heart block. Br Heart J 1960;22(5):691.
  • Peigh G, Leya MV, Baman JR, Cantey EP, Knight BP, Flaherty JD. Novel coronavirus 19 (COVID-19) associated sinus node dysfunction: a case series. Eur Heart J Case Rep 2020;4(FI1):1–6.
  • Figliozzi S, Masci PG, Ahmadi N, Tondi L, Koutli E, Aimo A, et al. Predictors of adverse prognosis in COVID-19: a systematic review and meta-analysis. Eur J Clin Invest 2020;50(10):e13362.
  • Babapoor-Farrokhran S, Gill D, Walker J, Rasekhi RT, Bozorgnia B, Amanullah A. Myocardial injury and COVID-19: possible mechanisms. Life Sci 2020;253:117723.
  • Mahdawi TE, Wang H, Haddadin FI, Al-Qaysi D, Wylie JV. Heart block in patients with coronavirus disease 2019: a case series of 3 patients infected with SARS-CoV-2. HeartRhythm Case Rep 2020;6(9):652–656.
  • Published: 2022-02-23

    Issue: 2022: Vol 9 No 2 (view)

    Section: Articles

    How to cite:
    1.
    Hussain M, Awuah D, Deliwala S, Alkotob L, Seedahmed E, Bachuwa G. The Management of Acute Onset Complete Heart Block and Atrial Flutter in a Patient with COVID-19. EJCRIM 2022;9 doi:10.12890/2022_003026.